Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.22.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Preferred Stock
Cumulative Effect Period of Adoption Adjusted Balance
Preferred Stock
Common Stock
Cumulative Effect Period of Adoption Adjusted Balance
Common Stock
Additional Paid-in- Capital
Cumulative Effect Period of Adoption Adjusted Balance
Additional Paid-in- Capital
Treasury Stock
Cumulative Effect Period of Adoption Adjusted Balance
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect Period of Adoption Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Cumulative Effect Period of Adoption Adjustment
Accumulated Deficit
Cumulative Effect Period of Adoption Adjusted Balance
Accumulated Deficit
Cumulative Effect Period of Adoption Adjustment
Cumulative Effect Period of Adoption Adjusted Balance
Total
Increase (Decrease) in Stockholders' Equity                                
Net loss                         $ (31,548)     $ (31,548)
Issuance of shares in connection with stock option exercise           $ 460                   460
Issuance of shares in connection with stock option exercise (in shares)       305                        
Issuance of shares in connection with restricted stock units vesting           (302)                   (302)
Issuance of shares in connection with restricted stock units vesting (in shares)       795                        
Issuance of shares in connection with BOD Fees           19                   19
Issuance of shares in connection with BOD Fees (in shares)       16                        
Share-based compensation           3,710                   3,710
Dividends on preferred stock           121       $ (313)     (160)     (352)
Dividends on preferred stock (in shares)       59                        
Ending balance at Dec. 28, 2019   $ 3   $ 38   187,147   $ (7,146)   214     (167,876)     12,380
Increase (Decrease) in Stockholders' Equity                                
Effect of changes in foreign currencies                   (52)           (52)
Beginning balance at Dec. 29, 2018 $ 3 $ 3 $ 38 $ 38 $ 183,139 183,139 $ (7,146) (7,146) $ 579 579 $ 1,623 $ (136,168) (137,791) $ 1,623 $ 40,445 38,822
Ending balance (in shares) at Dec. 28, 2019   2,771   36,167                        
Beginning balance (in shares) at Dec. 29, 2018 2,771 2,771 34,992 34,992                        
Increase (Decrease) in Stockholders' Equity                                
Net loss                         (1,513)     (1,513)
Issuance of common stock, net of underwriters' offering expenses and commissions       $ 5   60,456                   60,461
Issuance of common stock, net of underwriters' offering expenses and commissions (in shares)       4,900                        
Issuance of shares in connection with stock option exercise       $ 3   3,703                   $ 3,706
Issuance of shares in connection with stock option exercise (in shares)       2,200                       2,200
Issuance of shares in connection with restricted stock units vesting       $ 2   457                   $ 459
Issuance of shares in connection with restricted stock units vesting (in shares)       2,000                        
Issuance of shares in connection with BOD Fees           22                   22
Issuance of shares in connection with BOD Fees (in shares)       8                        
Share-based compensation           8,437                   8,437
Stock repurchase                               0
Dividends on preferred stock           38             (72)     (34)
Dividends on preferred stock (in shares)       45                        
Conversion of preferred stock   $ (3)   $ 3                        
Conversion of preferred stock (in shares)   (2,771)   2,771                        
Actuarial gain (loss) on defined benefit plan                   (400)           (400)
Unrealized gain on investments                   57           57
Ending balance at Jan. 02, 2021       $ 51   260,260   (7,146)   (215)     (169,461)     83,489
Increase (Decrease) in Stockholders' Equity                                
Effect of changes in foreign currencies                   (86)           (86)
Beginning balance at Dec. 28, 2019   $ 3   $ 38   187,147   (7,146)   214     (167,876)     12,380
Ending balance (in shares) at Jan. 02, 2021       48,091                        
Beginning balance (in shares) at Dec. 28, 2019   2,771   36,167                        
Increase (Decrease) in Stockholders' Equity                                
Net loss                         (10,339)     (10,339)
Issuance of shares in connection with stock option exercise       $ 2   3,659                   $ 3,661
Issuance of shares in connection with stock option exercise (in shares)       2,060                       2,060
Issuance of shares in connection with restricted stock units vesting       $ 3   986                   $ 989
Issuance of shares in connection with restricted stock units vesting (in shares)       2,665                        
Issuance of shares in connection with BOD Fees           23                   23
Issuance of shares in connection with BOD Fees (in shares)       1                        
Registration costs - common stock           (68)                   (68)
Issuance of stock awards           778                   778
Issuance of stock awards       143                        
Director and officer stock purchasing plan           4                   4
Share-based compensation           17,066                   17,066
Stock repurchase           (45)   (479)               (524)
Actuarial gain (loss) on defined benefit plan                   307           307
Unrealized gain on investments                   89           89
Ending balance at Jan. 01, 2022       $ 56   282,663   (7,625)   274     (179,800)     95,568
Increase (Decrease) in Stockholders' Equity                                
Effect of changes in foreign currencies                   93           93
Beginning balance at Jan. 02, 2021       $ 51   $ 260,260   $ (7,146)   $ (215)     $ (169,461)     $ 83,489
Ending balance (in shares) at Jan. 01, 2022       52,960                        
Beginning balance (in shares) at Jan. 02, 2021       48,091